2021
DOI: 10.3390/biomedicines9070762
|View full text |Cite
|
Sign up to set email alerts
|

Role of Leptin in Non-Alcoholic Fatty Liver Disease

Abstract: Non-alcoholic fatty liver disease (NAFLD), which affects about a quarter of the global population, poses a substantial health and economic burden in all countries, yet there is no approved pharmacotherapy to treat this entity, nor well-established strategies for its diagnosis. Its prevalence has been rapidly driven by increased physical inactivity, in addition to excessive calorie intake compared to energy expenditure, affecting both adults and children. The increase in the number of cases, together with the h… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
46
0
2

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 55 publications
(61 citation statements)
references
References 103 publications
2
46
0
2
Order By: Relevance
“…Upregulated miR-200c-3p and miR-224-5p target the gene LEP and lead to its suppression ( Figure 7B and Supplementary Table 4 ). Hyperleptinemia has been shown to lead to the development of insulin resistance (the pathways of leptin and insulin cross), inhibition of lipid oxidation, and activation of lipogenesis by SREBP-1 in the liver ( Jiménez-Cortegana et al, 2021 ). Leptin can activate HSC, provoking the development of fibrosis ( Polyzos et al, 2011 ).…”
Section: Discussionmentioning
confidence: 99%
“…Upregulated miR-200c-3p and miR-224-5p target the gene LEP and lead to its suppression ( Figure 7B and Supplementary Table 4 ). Hyperleptinemia has been shown to lead to the development of insulin resistance (the pathways of leptin and insulin cross), inhibition of lipid oxidation, and activation of lipogenesis by SREBP-1 in the liver ( Jiménez-Cortegana et al, 2021 ). Leptin can activate HSC, provoking the development of fibrosis ( Polyzos et al, 2011 ).…”
Section: Discussionmentioning
confidence: 99%
“…Adipose tissue caused by obesity can secrete diverse adipokines, such as leptin, adiponectin, and resistin, as well as proinflammatory cytokines, resulting in insulin resistance and chronic low-grade inflammation in different tissues, including liver tissue ( 29 ). For example, emerging evidence shows that leptin plays essential roles in cancer development by increasing tumor cell proliferation, metastasis, chemoresistance and promoting angiogenesis via binding its receptor to regulate many downstream signaling pathways ( 30 , 31 ), as well as promoting NASH and liver fibrosis ( 32 ). Obesity impacts adipocytes to secrete proinflammatory cytokines such as interleukin (IL)-6 and tumor necrosis factor-α (TNF-α), and lipotoxicity induces hepatocyte death to activate Kupffer cells to produce those cytokines ( 33 ).…”
Section: Obesity and Hccmentioning
confidence: 99%
“…plays a key role in the regulation of both energy metabolism and obesity, and also takes part in different diseases and processes, including (but not limited to) reproduction [36], autoimmunity [37], glucose metabolism [38], non-alcoholic fatty liver disease [39] or cancer [40,41].…”
Section: Leptin At a Glancementioning
confidence: 99%
“…Leptin is produced not only in WAT, a dynamic organ with multiple functions (e.g., the regulation of metabolism and energy balance, or its involvement in both inflammatory and immune responses), but also other tissues such as placenta [ 32 ], mammary gland [ 33 ], ovary [ 34 ] or pituitary gland [ 35 ]. Leptin plays a key role in the regulation of both energy metabolism and obesity, and also takes part in different diseases and processes, including (but not limited to) reproduction [ 36 ], autoimmunity [ 37 ], glucose metabolism [ 38 ], non-alcoholic fatty liver disease [ 39 ] or cancer [ 40 , 41 ].…”
Section: Leptin At a Glancementioning
confidence: 99%